1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. ALPA LABORATORIES LTD.
Alpa Laboratories Ltd.
NSE: ALPA | BSE: 532878
Ask AI about Alpa Laboratories
52.80-3.18(-5.68%)
26,079

NSE 16 Nov, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Alpa Laboratories quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Alpa Laboratories quarterly results: revenue, profit, and P&L – 13 quarter history

  • POSITIVE

    Quarterly Revenue Alpa Laboratories Sep-2026 Quarterly Revenue is Rs 32 Cr which is growth of 9.8% YoY.

  • NEGATIVE

    Quarterly Net Profit Alpa Laboratories Sep-2026 Quarterly Net Profit is Rs -2 Cr which is growth of -1947.9% YoY.

Alpa Laboratories Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphSep '26Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23
⌄
32.229.831.229.929.331.142.43531.926.627.630.835.4
Operating Exp.
33.227.927.827.528.518.739.525.421.720.920.124.929.1
Operating Profit
-2.2-43.62.1-2.90.4-0.40.73.30.53.52.53.3
Operating Profit Margin %
-7.16%-16.53%11.50%7.20%-11.19%2.22%-0.92%2.84%13.12%2.53%14.90%9.01%10.23%
Depr.
0.80.70.20.70.70.60.60.60.50.50.50.70.5
Interest
0.10.10.200.10.10.10.10.10.10.300
Profit Before Tax
-1.9131.70.111.82.38.99.65.16.75.35.7
Tax
1.7-0.24.223.10.8
Net Profit
-1.911.41.90.111.8-28.97.65.13.64.55.7
EPS Adj. latest
-0.90.50.60.90.15.6-0.94.23.62.41.72.22.7
Net profit TTM
2.44.415.111.818.826.419.725.220.818.916.817.918.5
Basic EPS TTM
1.12.17.25.6912.59.4129.9988.58.8
Results PDF
  
Result Notes
 
*All financials are in INR Cr and price data in INR

Alpa Laboratories competitor comparison and performance snapshot within industry

Alpa Laboratories annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

  • NEGATIVE

    Annual Revenue Alpa Laboratories Mar-2026 Annual Revenue is Rs 122 Cr which is growth of -10.5% YoY.

  • NEGATIVE

    Annual Net Profit Alpa Laboratories Mar-2026 Annual Net Profit is Rs 15 Cr which is growth of -24.0% YoY.

Alpa Laboratories Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17Mar '16
5.9%
3.6%
123.1121.5135.8123.6102.4123.110288.983.1677059.6
Operating Exp. Ann.
6.5%
2.7%
116.4102.5107.5100.684.9101.689.982.57758.356.346.7
Operating Profit Ann.
-25.9%
-15.6%
-0.43.358.18.110.77.73.5147.16.8
OPM Ann. %
-29.9%
-18.5%
 2.72%3.69%6.59%7.89%8.68%7.56%3.88%1.21%5.90%10.16%11.44%
⌄
6.7%
2.8%
 104.9109.9102.986.4103.591.283.978.760.458.749
EBITDA Ann.
2.8%
9.4%
 1928.32317.521.512.16.46.18.713.712.9
EBITDA Ann. margin %
-2.9%
5.6%
 15.65%20.85%18.62%17.08%17.45%11.89%7.22%7.31%12.94%19.58%21.66%
Interest Ann.
14.5%
24.6%
0.40.30.30.40.20.20.10.20.61.11.71.5
Depr.
17.3%
11.8%
2.42.12.221.31.71.21.11.11.10.80.8
PBT Ann.
1.4%
9%
3.916.625.820.715.919.610.85.14.46.69.110.6
Tax Ann.
-19.8%
-13.4%
1.51.76.23.93.35.53.511.71.83.12.9
6%
15.5%
 1519.716.812.614.17.34.12.74.867.7
Net Profit Ann.
6%
15.5%
2.41519.716.812.614.17.34.12.74.867.7
NPM Ann. %
1.3%
13.7%
 14.13%17.50%15.42%13.58%12.58%7.44%4.74%3.50%7.65%9.45%14.46%
EPS Adj. latest Ann.
5.8%
15.2%
 7.19.4866.73.51.91.32.32.93.7
Result Notes
   
Annual Reports
 
*All financials are in INR Cr and price data in INR
Total Rev. Ann.
1Y CHG
-10.5%
2Y CAGR
-0.9%
3Y CAGR
5.9%
5Y CAGR
3.6%
7Y CAGR
5.6%
10Y CAGR
7.4%
Total Revenue Annual is falling faster than historical averages.
Net Profit Ann.
1Y CHG
-23.9%
2Y CAGR
-5.5%
3Y CAGR
6%
5Y CAGR
15.5%
7Y CAGR
27.8%
10Y CAGR
6.9%
Net Profit Annual is falling faster than historical averages.
Operating Exp. Ann.
1Y CHG
-4.7%
2Y CAGR
0.9%
3Y CAGR
6.5%
5Y CAGR
2.7%
7Y CAGR
4.2%
10Y CAGR
8.2%
Operating Expenses Annual Cr is falling faster than historical averages.

Alpa Laboratories balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

  • POSITIVE

    Total Shareholders Fund Alpa Laboratories Mar-2026 Total Shareholders Fund is Rs 197 Cr which is growth of 8.1% YoY.

  • POSITIVE

    Total Assets Alpa Laboratories Mar-2026 Total Assets is Rs 251 Cr which is growth of 7.9% YoY.

Alpa Laboratories Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17Mar '16
⌄
10.8%
10.8%
196.6181.8162144.5131.6117.5110.2105.9103.298.594.3
Minority Interest Liability Ann.
-
-
-----------
⌄
2.1%
75.2%
3.34.52.43.14.70.20.20.40.60.50.6
19.9%
9.6%
51.546.728.129.928.832.520.822.322.730.150.1
Total Capital Plus Liabilities Ann.
12.3%
10.9%
251.4233192.4177.5165.1150.2131.2128.6126.6129.1145.1
⌄
42.4%
18.1%
20.220.711.579.38.87.25.96.15.24.5
⌄
13.3%
7%
42.641.532.729.327.430.436.935.730.621.429.2
12.1%
11.7%
208.8191.5159.8148.2137.7119.994.392.996.1107.7115.8
Total Assets Ann.
12.3%
10.9%
251.4233192.4177.5165.1150.2131.2128.6126.6129.1145.1
Contingent Liabilities plus Commitments Ann.
60.7%
20.9%
13.76.710.63.35.35.35.84.13.12.241.8
Bonus Equity Share Capital Ann.
-
-
Non Current Investments Unquoted Book Value Ann.
1%
-8.3%
6.67.46.96.45.910.217.329.323.715.615
Current Investments Unquoted Book Value Ann.
777.2%
239.3%
135110.591.10.20.20.339.33017.77.9
*All financials are in INR Cr and price data in INR
Total Assets Ann.
1Y CHG
7.9%
2Y CAGR
14.3%
3Y CAGR
12.3%
5Y CAGR
10.9%
7Y CAGR
10%
10Y CAGR
5.7%
Total Assets Annual growth is lower than historical averages.
Total Current Liabilities Ann.
1Y CHG
10.3%
2Y CAGR
35.4%
3Y CAGR
19.9%
5Y CAGR
9.6%
7Y CAGR
12.7%
10Y CAGR
0.3%
Total Current Liabilities Annual Cr growth is stable compared to historical averages.
Total ShareHolders Funds Ann.
1Y CHG
8.1%
2Y CAGR
10.2%
3Y CAGR
10.8%
5Y CAGR
10.8%
7Y CAGR
9.2%
10Y CAGR
7.6%
Total ShareHolders Funds Annual growth is lower than historical averages.

Alpa Laboratories ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

  • POSITIVE

    Book Value Per Share Alpa Laboratories Mar-2026 Book Value Per Share is 93 Rs which is growth of 8.1% YoY.

  • POSITIVE

    ROE Alpa Laboratories Mar-2026 ROE is 8% which is growth of 3.2% YoY.

Alpa Laboratories Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17Mar '16
BVSH Ann.
10.8%
10.8%
93.486.47768.762.655.952.450.349.146.844.8
RoA Ann. %
-5.8%
4.2%
5.94%8.44%8.71%7.11%8.55%4.83%3.10%2.12%3.76%4.64%5.33%
ROE Ann. %
-4.5%
4.2%
7.60%10.82%10.35%8.73%10.73%6.18%3.69%2.57%4.61%6.08%8.20%
ROCE Ann. %
-8.2%
-1.7%
8.46%14.01%12.81%10.94%14.54%9.24%4.77%4.67%7.33%13.07%12.72%
⌄
           
⌄
           
⌄
           
Total Debt to Total Equity Ann.
0 000  00.10.10.3
*All financials are in INR Cr and price data in INR
ROE Ann. %
1Y CHG
-29.8%
2Y CAGR
-14.3%
3Y CAGR
-4.5%
5Y CAGR
4.2%
7Y CAGR
16.8%
10Y CAGR
-0.8%
ROE Annual % is falling faster than historical averages.
RoA Ann. %
1Y CHG
-29.6%
2Y CAGR
-17.4%
3Y CAGR
-5.8%
5Y CAGR
4.2%
7Y CAGR
15.9%
10Y CAGR
1.1%
RoA Annual % is falling faster than historical averages.
Current Ratio Ann.
2Y CAGR
-15.2%
3Y CAGR
-6.4%
5Y CAGR
2.1%
7Y CAGR
-0.3%
10Y CAGR
6%
Current Ratio Annual is falling faster than historical averages.

Alpa Laboratories cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

  • NEGATIVE

    Cash From Operating Activity Alpa Laboratories Mar-2026 Cash From Operating Activity is Rs 10 Cr which is growth of -45.9% YoY.

  • NEGATIVE

    Net Cash Flow Alpa Laboratories Mar-2026 Net Cash Flow is Rs -0 Cr which is growth of -210.8% YoY.

Alpa Laboratories Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17Mar '16
4.4%
-
1018.43.78.82.2-1.517.7-0.8-7.3-8.1-24.8
Cash from Investing Act. Ann.
-
-
-11.6-12.5-12.52.1-17.25.8-11.3-2.4-15.81.1-7
Cash from Financing Act. Ann.
-
-
1.2-5.52.3-3.55.4-0-1.4-4.94.4-2.4-5.6
-
-
-0.50.4-6.57.5-9.64.35-8.1-18.7-9.4-37.4
*All financials are in INR Cr and price data in INR
Cash from Operating Act. Ann.
1Y CHG
-45.7%
2Y CAGR
64.4%
3Y CAGR
4.4%
Cash from Operating Activity Annual is falling faster than historical averages.
Cash from Financing Act. Ann.
2Y CAGR
-27.8%
Cash from Financing Annual Activity growth is lower than historical averages.

Alpa Laboratories investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access